Library Logo

Biophysical characterization of proteins in developing biopharmaceuticals / (Record no. 246962)

000 -LEADER
fixed length control field 05714cam a2200565Mi 4500
001 - CONTROL NUMBER
control field ocn891381891
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20190328114808.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 140918t20152015ne a ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency E7B
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency E7B
Modifying agency OCLCO
-- UIU
-- N$T
-- OCLCF
-- OCLCQ
-- YDXCP
-- YDX
-- BUF
-- MERER
-- OCLCO
-- OCLCQ
-- U3W
-- OCLCO
-- D6H
-- CHVBK
-- OCLCO
-- AU@
-- OCLCQ
-- OCLCO
-- OCLCA
-- YOU
-- OCLCO
-- OCLCA
019 ## -
-- 899273857
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780444595904
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0444595902
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9780444595737
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 0444595732
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)891381891
Canceled/invalid control number (OCoLC)899273857
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM301.4
Item number .B567 2015eb
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number QU 55
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 071000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.7
Edition number 23
245 00 - TITLE STATEMENT
Title Biophysical characterization of proteins in developing biopharmaceuticals /
Medium [electronic resource]
Statement of responsibility, etc. edited by Damian J. Houde, Steven A. Berkowitz.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Amsterdam, Netherlands :
Name of producer, publisher, distributor, manufacturer Elsevier,
Date of production, publication, distribution, manufacture, or copyright notice 2015.
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice �2015
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (427 pages) :
Other physical details illustrations
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index at the end of each chapters.
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Online resource; title from PDF title page (ebrary, viewed September 17, 2014).
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Front Cover; Biophysical Characterization of Proteins in Developing Biopharmaceuticals; Copyright; Contents; List of Contributors; About the Editors; Preface; List of Abbreviations and Symbols; Chapter 1 -- The Complexity of Protein Structure and the Challenges it Poses in Developing Biopharmaceuticals; 1.1 THE BASICS OF PROTEIN HIGHER-ORDER STRUCTURE (HOS); 1.2 THE SEARCH FOR HOW PROTEINS ATTAIN THEIR CORRECT HOS: THE PROTEIN FOLDING PROBLEM; 1.3 SURPRISES IN THE WORLD OF PROTEIN FOLDING: INTRINSICALLY DISORDERED OR UNSTRUCTURED PROTEINS (AN APPARENT CHALLENGE TO THE ...
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 1.4 PROTEINS AND THE BIOPHARMACEUTICAL INDUSTRY: PROBLEMS AND CHALLENGES1.5 CONCLUSION; References; Further Reading; Chapter 2 -- Biophysical Characterization and Its Role in the Biopharmaceutical Industry; 2.1 DRUG DEVELOPMENT PROCESS; 2.2 PROTEIN DRUGS (BIOPHARMACEUTICALS); 2.3 THE ROLE OF BIOPHYSICAL CHARACTERIZATION IN BIOPHARMACEUTICAL DRUG DEVELOPMENT; 2.4 THE CHALLENGES IN CONDUCTING BIOPHYSICAL MEASUREMENTS TO DETECT CHANGES IN A PROTEIN DRUG''S HOS; 2.5 REGULATORY NEEDS AND CONSIDERATIONS; References; Further Reading; Chapter 3 -- Biopharmaceutical Industry''s Biophysical Toolbox.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 3.1 ATTRIBUTES OF A SINGLE BIOPHYSICAL TOOL TO CHARACTERIZE AND DETECT CHANGES IN THE HIGHER ORDER STRUCTURE OF A BIOPHARMACEUTICAL3.2 STUDYING THE BIOPHYSICAL PROPERTIES OF A BIOPHARMACEUTICAL AS AN INDIRECT APPROACH FOR CHARACTERIZING CHANGES IN ITS HOS; 3.3 GENERAL CONSIDERATIONS IN ANALYZING THE BIOPHYSICAL PROPERTIES OF BIOPHARMACEUTICALS; 3.4 THE UTILITY OF USING STRESS TO MONITOR CHANGES IN THE HOS PROFILE OF A PROTEIN DRUG; 3.5 PRESENT BIOPHYSICAL TOOLBOX; 3.6 CONCLUSION; References; Further Reading.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Chapter 4 -- An Introduction and Hierarchical Organization of the Biophysical Tool in Section II4.1 INTRODUCTION; 4.2 THE STANDARD CLASS OF BIOPHYSICAL TOOLS USED IN THE BIOPHARMACEUTICAL INDUSTRY; 4.3 THE ADVANCED CLASS OF BIOPHYSICAL TOOLS USED IN THE BIOPHARMACEUTICAL INDUSTRY; 4.4 AN OVERVIEW OF SECTION II; References; Further Reading; Chapter 5 -- The Value of UV, Fluorescence, and FTIR Spectroscopy in Biopharmaceutical Development; 5.1 INTRODUCTION; 5.2 THE ORIGINS OF ELECTRONIC ABSORPTION, FLUORESCENCE, AND FT-IR SPECTROSCOPY; 5.3 CONFORMATIONAL ANALYSIS OF PROTEINS IN SOLUTION.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 5.4 OPTICAL SPECTROSCOPY AND PRODUCT COMPARABILITY5.5 OPTICAL SPECTROSCOPY AND HIGH-THROUGHPUT METHODS; 5.6 SOLID-STATE MEASUREMENTS; 5.7 CONCLUSIONS; References; Chapter 6 -- Circular Dichroism Spectroscopy for Protein Characterization: Biopharmaceutical Applications; 6.1 INTRODUCTION; 6.2 INSTRUMENTATION; 6.3 DATA GENERATED; 6.4 GUIDE TO COLLECTING GOOD DATA; 6.5 DATA PROCESSING AND ANALYSES; 6.6 ROLE IN THE RESEARCH INDUSTRY; 6.7 TECHNOLOGY AVAILABILITY; 6.8 FUTURE DEVELOPMENTS; Acknowledgments; References; Further Reading.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Chapter 7 -- Size-Exclusion Chromatograph (SEC) in Biopharmaceutical Process Development.
520 ## - SUMMARY, ETC.
Summary, etc. Biophysical Characterization of Proteins in Developing Biopharmaceuticals is concerned with the analysis and characterization of the higher-order structure (HOS) or conformation of protein based drugs. Starting from the very basics of protein structure this book takes the reader on a journey on how to best achieve this goal using the key relevant and practical methods commonly employed in the biopharmaceutical industry today as well as up and coming promising methods that are now gaining increasing attention. As a general resource guide this book has been written with the intent to help tod.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biopharmaceutics.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Pharmacology.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biopharmaceutics.
Source of heading or term fast
Authority record control number (OCoLC)fst00832650
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Proteins
General subdivision analysis.
Authority record control number (DNLM)D011506Q000032
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biopharmaceutics.
Authority record control number (DNLM)D001702
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Technology, Pharmaceutical.
Authority record control number (DNLM)D013678
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Houde, Damian J.,
Relator term editor.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Berkowitz, Steven A.,
Relator term editor.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Title Biophysical characterization of proteins in developing biopharmaceuticals.
Place, publisher, and date of publication Amsterdam, Netherlands : Elsevier, �2015
Physical description xxi, 404 pages
International Standard Book Number 9780444595737
856 40 - ELECTRONIC LOCATION AND ACCESS
Materials specified ScienceDirect
Uniform Resource Identifier http://www.sciencedirect.com/science/book/9780444595737

No items available.

Last Updated on September 15, 2019
© Dhaka University Library. All Rights Reserved|Staff Login